Home » Topics » Respiratory, BioWorld Science

Respiratory, BioWorld Science
RSS

Nikken Chemicals develops new agents for asthma

March 17, 1998

The role of Ca2+-activated K+ channels in bronchorelaxation by NKH-477

March 17, 1998

First market introduction for Allegra-D

March 16, 1998

Hoechst Marion Roussel and 3M establish marketing agreement for asthma products

March 13, 1998

Milkhaus receives patent protection for DNA treatment of respiratory disorders

March 13, 1998

Interim safety data reported for Procysteine

March 12, 1998

Rhone-Poulenc Rorer synthesizes and evaluates new TNF/cAMP PDE inhibitors

March 12, 1998

First launch for Synthelabo antihistamine

March 11, 1998

Clinical syndromes associated with zafirlukast therapy in patients with asthma

March 10, 1998

Yamanouchi engages in NK antagonist research

March 6, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...